[Pulmonary alveolar proteinosis in two siblings. A case report]

Sonia Halioui-Louhaïchi1, Mongi Ben Hariz, Anies Hamzaoui

  • 1Service de Pédiatrie Hôpital Mongi Slim, La Marsa.

La Tunisie Medicale
|October 22, 2005
PubMed

Insights

Pulmonary alveolar proteinosis (PAP) in children is rare. This case study details two siblings with PAP, highlighting successful treatment with therapeutic whole lung lavages, leading to improved respiratory function in one sibling.

Area of Science:

  • Pediatric Pulmonology
  • Rare Genetic Disorders
  • Respiratory Medicine

Background:

  • Pulmonary alveolar proteinosis (PAP) is a rare pediatric lung disease characterized by surfactant accumulation in alveoli.
  • Genetic factors are implicated in some forms of PAP, necessitating further research into familial cases.
  • Early diagnosis and intervention are crucial for managing pediatric PAP and preventing long-term respiratory compromise.

Observation:

  • This report details a unique case of PAP in infant siblings, presenting with differing clinical timelines and severity.
  • The female sibling experienced chronic respiratory distress, while the male sibling remained asymptomatic.
  • Diagnostic methods included open lung biopsy and bronchoalveolar lavage, confirming PAP in both siblings.

Findings:

  • Therapeutic whole lung lavages were administered to both siblings, with the female undergoing six procedures and the male two.
  • The female sibling achieved independence from oxygen therapy post-lavage, demonstrating treatment efficacy.
  • Long-term follow-up revealed sustained asymptomatic status in the male sibling and two resolved episodes of respiratory distress in the female sibling.

Implications:

  • Therapeutic whole lung lavage is an effective treatment for pediatric pulmonary alveolar proteinosis, improving respiratory outcomes.
  • Familial occurrence of PAP underscores the importance of genetic counseling and screening in affected families.
  • This case highlights the successful application of therapeutic lavages by a Tunisian medical team, expanding global expertise in managing this rare condition.

Related Concept Videos

Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...